Cyteir Therapeutics
Why Robinhood?
You can watch CYTT and buy or sell other stocks, ETFs, and their options commission-free!About CYTT
Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies.
CYTT Key Statistics
Stock Snapshot
With a market cap of 108.35M, Cyteir Therapeutics(CYTT) trades at $3.01. The stock has a price-to-earnings ratio of -3.23.
Cyteir Therapeutics(CYTT) stock opened on 2026-05-01 at —. The price climbed to — and dipped to —.
Cyteir Therapeutics(CYTT) shares are trading with a volume of 0, against a daily average of 645.29K.
During the past year, Cyteir Therapeutics(CYTT) stock moved between $1.65 at its lowest and $3.19 at its peak.
During the past year, Cyteir Therapeutics(CYTT) stock moved between $1.65 at its lowest and $3.19 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.